Strata to Help Epizyme Find Patients for Non-Hodgkin Lymphoma Trial of Tazemetostat
News
Strata Oncology will help Epizyme accelerate patient enrollment in the Phase 2 clinical trial assessing Epizyme’s EZH2 inhibitor tazemetostat in patients with relapsed or refractory non-Hodgkin lymphoma. Strata is conducting ... Read more